ID: ALA2172436

Max Phase: Preclinical

Molecular Formula: C18H15N3O

Molecular Weight: 289.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC1=CC(c2cc3ccccc3[nH]2)=N/C1=C\c1ccc[nH]1

Standard InChI:  InChI=1S/C18H15N3O/c1-22-18-11-16(21-17(18)10-13-6-4-8-19-13)15-9-12-5-2-3-7-14(12)20-15/h2-11,19-20H,1H3/b17-10-

Standard InChI Key:  XJDIRFYUCDVZPF-YVLHZVERSA-N

Associated Targets(Human)

Protein-tyrosine phosphatase 1C 687 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 289.34Molecular Weight (Monoisotopic): 289.1215AlogP: 3.87#Rotatable Bonds: 3
Polar Surface Area: 53.17Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.97CX Basic pKa: 4.57CX LogP: 2.43CX LogD: 2.43
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.76Np Likeness Score: -0.24

References

1. Su JC, Chen KF, Chen WL, Liu CY, Huang JW, Tai WT, Chen PJ, Kim I, Shiau CW..  (2012)  Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists.,  56  [PMID:22982119] [10.1016/j.ejmech.2012.08.024]

Source